全球動物用疫苗市場 (各動物疾病，各技術，動物的各類型，各地區) :趨勢與預測 (2014年∼2019年)
Global Veterinary Vaccines Market Segmented by Animal diseases , by Technology, by Animal Type & by Geography - Trends and Forecast 2014-2019
|出版商||Mordor Intelligence LLP||商品編碼||353778|
|全球動物用疫苗市場 (各動物疾病，各技術，動物的各類型，各地區) :趨勢與預測 (2014年∼2019年) Global Veterinary Vaccines Market Segmented by Animal diseases , by Technology, by Animal Type & by Geography - Trends and Forecast 2014-2019|
|出版日期: 2016年01月01日||內容資訊: 英文||
The Global market for Veterinary Vaccines is currently estimated to be valued at $12.35 billion for the year 2015 and is poised to reach $21.19 billion by the end of 2020. The CAGR during this period of forecast is 11.41%.
Growing numbers of farm and companion animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare.
Factors responsible for the growth of the market are increasing Zoonotic diseases, increasing investments by government bodies, animal welfare associations and leading players. Recent epidemics like swine flu, avian influenza and anthrax created awareness among livestock owners to avoid the huge production losses due to these diseases.
The future of the animal vaccines will be dominated by DNA-related vaccine which can target the particular disease with minimal vaccines shots. Such innovative products will be more capable of providing protection than the conventional vaccines.
However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.
Veterinary vaccine market has shown growth in recent years which can be attributed to increasing husbandry practices and better management of farms. This results in estimation of further growth in the market due to advancement in biotechnological research. In country wise analysis, Chinese animal vaccine market is set to grow because the R&D platform and technology has the capability to support the development of various veterinary vaccines and the expansion of governmental tender vaccine.
Europe accounts for the largest share of the animal vaccines market, followed by North America. While North America and Europe have decelerated growth in veterinary vaccines due to quality safety, high maturity and other factors, developing regions like Asia-pacific and other developing countries have fast growing animal vaccine market.
The global veterinary vaccine market is segmented by type of disease in companion and farm animal's poultry vaccines (Bronchitis, Avian Influenza, Mareks disease, New castle disease), Swine vaccines (Porcine reproductive disease, Swine influenza, Swine Pneumonia). By vaccine technology, the market is segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines and live attenuated vaccines and by geography, the market is divided into North America, Asia-Pacific, Europe and the rest of world.
Competitive Intelligence analysis in the form of Mergers & Acquisition activity, Collaborations, Agreements, New product launches along with the profiles of major players including the likes of Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva and a few others.
Increase in pet ownership, improved nutrition, intensifying consumer focus on food safety, greater livestock production rates and increasing foodborne diseases are the major factors contributing to the growth of the Veterinary Vaccines market.
However, scarcity of arable land and water, increased competition for cultivated land and cost effective production are the factors hindering the growth of the market.